‘Everyone acknowledges we’ve shown the proof of concept’: The fight for a population-based DNA screening program
Around one in 50 patients might unwittingly have a genetic time bomb — a gene variant that places them at substantially increased risk of early-onset cancer or heart disease.
Most will not know until they are diagnosed with late-stage disease.
The solution? Population-level DNA screening, says Associate Professor Jane Tiller, an associate professor in genomics and policy at Melbourne’s Monash University.
As co-lead of the DNA Screen study, she has helped build a case for preventive genetic screening of Australian adults.
